Ontario Expands Access to Dexcom G7 CGM Under the Ontario Drug Benefit (ODB) Program
Article content
BURNABY, British Columbia — Dexcom, Inc. (NASDAQ: DXCM), a global leader in glucose biosensing, applauds the Ontario government for its recent decision to include the Dexcom G7 Continuous Glucose Monitoring (CGM) System as part of the Ontario Drug Benefit (ODB) program for eligible Ontarians who manage their diabetes with insulin.*
Article content
Article content
Diabetes Canada estimates that 1.7 million people in Ontario are living with diabetes in 2024, with a significant portion requiring insulin for either type 1 or type 2 diabetes 1. This highlights a broad need for support across both types of diabetes for insulin therapy optimization.
Article content
This coverage expansion will grant access to Dexcom G7 to a broader population and make Dexcom G7 now the most covered CGM on government-funded programs in Ontario †,2 for people on insulin through the following programs:
Article content
Ontario Drug Benefit (ODB)
Article content
– for eligible residents on insulin aged 65+ or earlier if they:
Article content
Live in a long-term care home, home for special care, or Community Home for Opportunity
Are 24 or under without private insurance (OHIP+)
Receive professional home and community care
Get benefits from Ontario Works or ODSP
Are enrolled in the Trillium Drug Program
Article content
– for individuals with type 1 diabetes who meet the eligibility criteria.
Article content
Private Insurance
Article content
– most private insurance plans cover Dexcom G7 for anyone on insulin.
Article content
– for eligible First Nations and Inuit clients on insulin.
Article content
'This announcement represents a significant step forward for people managing diabetes in Ontario and their healthcare providers with more equitable access to Dexcom's life-changing CGM technology,' says André Côté, Vice President and General Manager of Dexcom Canada. 'By expanding coverage for Dexcom G7 under ODB, Ontario is recognizing the value of the #1 preferred glucose sensor by Canadian endocrinologists ‡, 3 for the management of insulin-using patients.'
Article content
Dexcom G7 is the most accurate CGM with clinically proven outcomes §,2 including lowering A1C, reducing hyper-and hypoglycemia, and increasing time in range for people with type 1 or type 2 diabetes 4-8. Featuring several unique alerts supporting safer insulin therapy, this increased access to Dexcom G7 is welcome news for both healthcare providers and their patients using insulin.
Article content
'As an endocrinologist, I've seen firsthand how continuous glucose monitoring has transformed diabetes management,' says Dr. Alexander Abitbol, Endocrinologist & Assistant Medical Director, LMC Healthcare. 'Managing diabetes is very personal, and being able to offer patients a choice on the most appropriate CGM technology with features tailored to help them meet their individualized care goals is critical.'
Article content
Dexcom G7 allows individuals to easily see their glucose levels in real-time to make more informed insulin treatment decisions. Users can see directly how medications affect their levels and gain insights on what keeps their levels stable, empowering them to learn what works in order to feel their best and stay motivated over time.
Article content
Discreet and easy to use, Dexcom G7 is the only sensor in Canada to offer these features for insulin therapy optimization and personalization for any lifestyle:
Article content
As the #1 patient recommended CGM in Canada ††,12, Dexcom G7 delivers both clinical and lifestyle benefits, and now more Ontarians than ever will have access to this technology for their diabetes management.
Article content
To learn more about Dexcom G7 and the public and private coverage options available, please visit dexcom.com. About Dexcom Dexcom empowers people to take control of health through innovative biosensing technology. Founded in 1999, Dexcom has pioneered and set the standard in continuous glucose monitoring for more than 25 years. Its technology has transformed how people manage diabetes and track their glucose, helping them feel more in control and live more confidently.
Article content
_______________________________________
* For ODB eligible persons who are on insulin therapy for diabetes and who have a valid prescription for Dexcom G7 from a physician or nurse practitioner. Limit of 45 Dexcom G7 Sensors per eligible person per 365-day period. Dexcom G7 Receivers are also covered if there is no compatible smart device. For detailed coverage criteria, please visit https://www.dexcom.com/en-CA/coverage/ontario-provincial-cgm-coverage.
† Dexcom G7 is the only CGM covered by ODB, ADP, most private insurance & NIHB for people on insulin. Eligibility and coverage vary by policy, plan, and payor. For insurance assistance call Dexcom Canada at 1-844-832-1810 with any questions.
‡ Based on a survey of Canadian Endocrinologists (n=41)
§ When compared with CGM systems commercially available in Canada as of October, 2023. Sensors worn on the back of the upper arm have been found to be slightly more accurate than sensors worn on the abdomen.
|| Audible and visual notification of predictive alert at 3.1 mmol/L within 20 minutes.
¶ The Dexcom G7 Sensor is waterproof and may be submerged under eight feet of water for up to 24 hours without failure when properly installed.
# Indicated for wear on the back of the upper arm and abdomen for ages 2 years and older or the upper buttocks for ages 2-6 years old.
** Smart device sold separately. To view a list of compatible devices, visit dexcom.com/compatibility. Compatible smartphone is required to pair a new Dexcom G7 sensor with a compatible Apple Watch.
†† Based on a comparison in NPS scores across major CGM brands
1 https://www.diabetes.ca/getmedia/b4f2add1-c56b-48e5-93cd-beb9feebb667/2024-Backgrounder-Ontario.pdf
2 Dexcom, data on file, 2025
3 Q&A, Dexcom Canadian Endos Report Wave 1 2024
4 Beck, RW, et al. JAMA. 2017;317(4):371-378.
5 Beck RW, et al. Ann Intern Med. 2017;167(6):365-374.
6 Martens T, et al. JAMA. 2021;325(22):2262-2272.
7 Laffel LM, et al. JAMA. 2020;323(23):2388-2396.
8 Welsh JB, et al. J Diabetes Sci Technol. 2024;18(1):143-7.
9 Dexcom G7 User Guide.
10 Aly A, et al. Diabetes Technol. Ther. 2024;26(S2): A254-255.
11 Puhr S, et al. Diabetes Technol Ther. 2019;21(4):155-158.
12 DQ&A, Canada Diabetes Connections Patient Panel Report, H1 2024
Article content
Article content
Article content
Article content
Article content
Contacts
Article content
Media Contact:
Article content
Article content
Cole Douglas
Article content
Article content
Article content
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
CTV News
4 hours ago
- CTV News
2,500 in Timmins-area to gain primary care providers with $1M in new funding
Northern Ontario Watch Timmins MPP George Pirie announced more than $1 million to get people connected with primary care physicians on Friday. Three area health teams submitted a proposal for the funding with the goal of serving more than 2,500 patients by adding new medical staff including doctors, nurse practitioners and administrators.
CTV News
6 hours ago
- CTV News
Edmonton's heat wave might be keeping mosquitos away: expert
Officials in Edmonton say recent hot weather is keeping the mosquito population at bay in the city. While most people appreciate some hotter days, it's fair to say that mosquitos are less well-received. According to city officials, sweltering days could be keeping the bloodsuckers at bay. 'We've had really dry conditions in Edmonton since the spring, and all the mosquitos need water in order to carry out their life cycle,' said Sarah McPike, a biological sciences technologist with the city. 'We've had relatively low numbers all summer long.' The most common type of mosquito in the area is the Culex pipiens species, or the common house mosquito. McPike said this summer they've been less than one per cent of the mosquito count. This bodes well for concerns about West Nile virus, as the first human case of the mosquito-transmitted disease was confirmed in Toronto on Thursday. There are a few species of mosquitos in the Edmonton area that could 'potentially' carry West Nile virus, McPike said, but the species they're catching in their traps with the city are 'not known to vector West Nile virus.' 'The mosquito carries the virus, and most of the time it's going to choose to bite a bird to get the blood that the female needs to grow its eggs,' she said. 'So they're much more likely to bite birds in our area than they are to bite people.' For people who are concerned, McPike said the best defence starts at home. 'Make sure you don't have much standing water in your backyard. Empty bird baths regularly, watch for flowerpots and things where you can make sure they don't have any standing water in them,' she said.
CTV News
7 hours ago
- CTV News
Bat in Pembroke, Ont. tests positive for rabies, health unit says
The Renfrew County and District Health Unit (RCDHU) says a bat that was found in Pembroke, Ont. has tested positive for rabies. The health unit said in a news release Friday that the bat was submitted as part of an investigation into possible human exposure and staff from the RCDHU have followed up with those involved to prevent rabies infection. 'Local human-bat exposures have been increasing in recent weeks and RCDHU is advising Renfrew County and District residents to remain vigilant about the risk of rabies. This animal rabies case is the first in Renfrew County and District this year,' the health unit said. According to the RCDHU 33 bats have been submitted for rabies testing since 2021 and of these 33, four (12 per cent) have tested positive for rabies. 'Rabies is a viral infection that causes inflammation of the brain and spinal cord, which is almost always fatal. Rabies is transmitted to humans through direct contact with saliva from an infected animal, usually through a bite, but saliva contamination of cuts, scratches, or mucous membrane is also possible. The animals that most commonly have rabies in Ontario are bats, skunks, and raccoons. Human rabies cases in Canada are very rare,' the health unit says. The Renfrew County and District Health Unit says residents can protect themselves against rabies with several tips: Vaccinate your pets against rabies; it is the law in Ontario that all cats, dogs, and ferrets over 3 months of age are vaccinated against rabies. Stay away from wild animals and always refrain from feeding, touching, or handling wildlife. Do not trap and transport wild animals to a new location. Warn children to stay away from wild or stray animals. Keep pets away from wild animals and do not let pets roam unsupervised. You can bat-proof your home or cottage by caulking holes in the exterior, even those as small as one-quarter to one-half inch in diameter; tightening screens, capping your chimney, placing draft guards under doors leading to the attic and outside, and filling plumbing fixture holes with steel wool or caulk; and keeping doors tightly closed when going outside and coming back indoors. If a bat gets into your home, it's recommended you confine the bat to one room, open a window and turn off the lights so that it can fly out on its own. If it doesn't leave, contact pest control experts who can humanely trap and release the animal. 'If the bat is found in a bedroom, there has been any direct contact with a child, or you cannot rule out exposure to the bat's saliva, call a healthcare provider or RCDHU at 613-732-3629 ext. 505 for advice immediately,' the health unit says. 'Bats have tiny teeth and a bite mark from a bat can be difficult to find.' If you have been bitten or scratched by an animal, the health unit recommends you collect the contact information of the animal's owner/custodian where applicable (their name, address and phone number), immediately thoroughly wash all bite or scratch wounds with soap and water, seek immediate medical attention to assess the need for post exposure treatment, and report the incident to the RCDHU at 613-732-3629 ext. 505 The RCDHU says rabies vaccines are highly effective at preventing the disease if administered soon after an exposure.
